| S.No. | Name of the Supervisor / Co-Supervisor |
Name of the Ph.D. Scholar | Mode of Ph.D. | Registration Number | Date of Registration | Research Topic | Likely Date of Completion | Availing Fellowship | Funding Agency of Fellowship |
| Faculty of Pharmaceutical Sciences : University Institute of Pharmaceutical Sciences | Updated on: 28/05/2024 | ||||||||
| 1. | Dr Gurpal Singh | Jatinder Kaur | Full Time | 23-24/459/Ph.D | 21/03/2024 | Yet to be approved | 20/03/2027 | Yes | DBT Biocare |
| 2. | Professor Alka Bali | Akshay Kumar | Full Time | 23-24/253/Ph.D | 31/01/2024 | Yet to be approved | 30/01/2029 | No | |
| 3. | Dr Amita Sarwal | Bharti Sunil Shivparsad | Full Time | 23-24/254/PH.D | 31/01/2024 | YET TO BE APPROVED | 30/01/2029 | Yes | IPCA Fellowship |
| 4. | Professor Indu Pal Kaur | Simrandeep Kaur | Full Time | 13-PHARM-42 | 31/01/2024 | Yet to be approved | 30/01/2027 | Yes | Curetech Skincare |
| 5. | Professor Kanwaljit Chopra Dr Sandip Pawar |
Zahid Bashir Zargar | Full Time | 23-24/220/PH.D | 23/01/2024 | Yet to be approved | 22/01/2029 | Yes | DST- SERB |
| 6. | PROFESSOR INDU PAL KAUR | MANEESHA RANA | Full Time | 23-24/62/Ph.D | 27/09/2023 | YET TO BE APPROVED | 27/09/2026 | Yes | DST INSPIRE |
| 7. | Professor Indu Pal Kaur | Navjot Sharma | Full Time | 23-24/64/Ph.D | 27/09/2023 | Yet to be approved | 26/09/2028 | Yes | UGC-JRF (CSIR) |
| 8. | Professor Kanwaljit Chopra | Neha Thakur | Full Time | 23-24/65/Ph.D | 27/09/2023 | Yet to be approved | 26/09/2028 | No | |
| 9. | Dr Amita Sarwal | Namarta Thakur | Full Time | 23-24/63/PH.D | 27/09/2023 | Yet to be approved | 26/09/2027 | No | |
| 10. | Dr Sandip Pawar | Pankaj Kumar | Full Time | 2023-EZ-34 | 27/09/2023 | Yet to be approved | 26/09/2029 | Yes | PU Fellowship |
| 11. | Professor Ranju Bansal | Jatinder Kaur | Full Time | 40316000014 | 27/09/2023 | Yet to be approved | 25/09/2026 | Yes | PU Ph.D Fellowship |
| 12. | Professor Indu Pal Kaur Professor O P Katare |
Srishti Naryal | Full Time | 22-23/468/Ph.D | 30/05/2023 | Yet to be approved | 29/05/2028 | Yes | IPCA Fellowship |
| 13. | Professor O P Katare Dr Vandita Kakkar |
Krishma | Full Time | 2022-EZ-103 | 06/03/2023 | Yet to be approved | 04/01/2027 | No | |
| 14. | Professor Kanwaljit Chopra Dr Mahendra Bishnoi |
Roshan LAL | Full Time | 22-23/262/PH.D | 21/02/2023 | Yet to be approved | 20/02/2027 | No | |
| 15. | Dr Sangeeta Pilkhwal Sah | Priyanka Puri | Full Time | 2022-EZ-78 | 02/02/2023 | Yet to be approved | No | ||
| 16. | Professor Indu Pal Kaur | Maneesha Rana | Full Time | DR&DC/DSTINSPIRE/2023/10 | 27/01/2023 | Design optimization and development of Nanoformulations for pain amelioration | 22/06/2027 | Yes | DST INSPIRE |
| 17. | Dr Vandita Kakkar | ParveenKumari | Full Time | 2022-EZ-53 | 07/10/2022 | Yet to be approved | Yes | DST-WOS-A | |
| 18. | Professor Anil Kumar | Rittu Banderwal | Full Time | 2022-EZ-24 | 05/09/2022 | Yet to be approved | 17/04/2026 | Yes | PU PhD fellowship |
| 19. | Dr Sangeeta Pilkhwal Sah | Saloni Rahi | Full Time | 2022-EZ-22 | 05/09/2022 | Yet to be approved | 31/08/2025 | No | |
| 20. | Dr Jai Malik | Shweta Parihar | Full Time | 2022-EZ-23 | 17/08/2022 | Yet to be approved | No | ||
| 21. | Dr Neelima Dhingra | Mansi Prashar | Full Time | 19-PHARM-38 | 08/08/2022 | Yet to be approved | 08/08/2026 | No | |
| 22. | Dr Anurag Kuhad Dr Koushik Ray |
Harsh Pawar | Full Time | 2022-EZ-01 | 27/06/2022 | Yet to be approved | No | ||
| 23. | Professor Kanwaljit Chopra Dr Manish Jain, Ramalingswamy Fellow, |
Ankan Sarkar | Full Time | 2022-EZ-18 | 19/05/2022 | Yet to be approved | Yes | DBT | |
| 24. | Professor Ranju Bansal | Ankit Bajpai | Full Time | 2021-EZ-173 | 20/04/2022 | Yet to be approved | No | ||
| 25. | Professor Ranju Bansal | Zahid Ahmad Dar | Full Time | 14-PHARM-44 | 20/04/2022 | Yet to be approved | 20/04/2027 | No | |
| 26. | Professor Indu Pal Kaur | Bakr Ahmed Hameed Al Maraseemi | Full Time | 21-22/192/Ph.D | 04/01/2022 | Yet to be approved | 03/01/2026 | No | |
| 27. | Professor Poonam Piplani | Ajay Kumar | Full Time | 2021-EZ-83 | 04/01/2022 | Yet to be approved | 04/01/2027 | No | |
| 28. | Professor Anil Kumar | Garima Sharma | Full Time | 2021-EZ-78 | 10/12/2021 | PHARMACOLOGICAL INVESTIGATIONS TARGETING NLRP-3 INFLAMMASOMES IN EXPERIMENTAL MODELS OF DEPRESSION | 08/12/2025 | No | |
| 29. | Professor V R Sinha | Deepshikha | Full Time | 2021-EZ-79 | 08/11/2021 | PREPARATION AND CHARACTERIZATION OF NOVEL FORMULATIONS OF NEPAFENAC FOR THE MANAGEMENT OF OCULAR INFLAMMATION | 07/11/2025 | No | |
| 30. | Dr Sandip V. Pawar Dr Sangeeta Pilkhwal Sah |
Khushboo Pathania | Full Time | 12-PHARM-20 | 11/10/2021 | Design and development of novel drug delivery system for cancer therapy | 01/10/2026 | Yes | CSIR |
| 31. | Professor Kanwaljit Chopra | Rohini Sharma | Full Time | 2021-EZ-39 | 16/08/2021 | EVALUATING THE IMPACT OF ACCELERATED DRUGS APPROVALS BASED ON SURROGATE ENDPOINTS IN ONCOLOGY CLINICAL RESEARCH AND PRACTICE | No | ||
| 32. | Dr Ashok Kumar Yadav Dr Jayeeta Bhaumik, Centre of Innovation & Applied Bioprocessing |
Kunal Gogde | Full Time | 2021-EZ-07 | 12/07/2021 | DESIGN AND SYNTHESIS OF PYRROLE-BASED PHOTOSENSITIZERS AND THEIR AGRI-BIOMASS-DERIVED NANOFORMULATIONS FOR IN-VITRO ANTIMICROBIAL AND ANTICANCER PHOTODYNAMIC THERAPY | 12/07/2024 | No | |
| 33. | Dr Gurpal Singh | Akhil Khajuria | Full Time | 18-PHARM-01 | 04/06/2021 | Yet to be approved | 20/12/2024 | No | |
| 34. | Professor Kanwaljit Chopra, Dr Kanthi Kiran Kondepudi (National Agri-Food Biotechnology Institute, Mohali) Dr Mahendra Bishnoi |
Tushar Matta | Full Time | 2020-EZ-155 | 15/03/2021 | STUDIES ON GUT MICROBIOTA MODULATION IN KINDLING EPILEPSY | 15/08/2025 | No | |
| 35. | Dr Neelima Dhingra Dr Tanzeer Kaur |
Priyanka Rana | Full Time | 15-PHARM-57 | 11/01/2021 | DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME D-RING MODIFIED 3β-SUBSTITUTED ANDROSTANE DERIVATIVES FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA | 10/01/2024 | No | |
| 36. | Dr Sandip V. Pawar | Sunil Kumar | Full Time | 12-pharm-42 | 17/12/2020 | EVALUATION OF PYRIDINE-FUSED BICYCLIC HETEROCYCLES FOR COLORECTAL CANCER | 31/08/2024 | No | |
| 37. | Professor Anil Kumar Professor Milind Parle |
Priya Joon | Full Time | 2020-EZ-08 | 17/09/2020 | PHARMACOLOGICAL INVESTIGATIONS TO EXPLORE THE POTENTIAL ROLE OF DIETARY INTERVENTIONS IN THE MANAGEMENT OF AUTISM SPECTRUM DISORDER | 17/09/2024 | No | |
| 38. | Professor Indu Pal Kaur | Pratibha | Full Time | 2020-EZ-06 | 08/09/2020 | FORMULATION, OPTIMIZATION AND EVALUATION OF NANOENCAPSULATED SALIVARY PEPTIDES LOADED HYDROGEL DRESSINGS | 08/09/2024 | No | |
| 39. | Professor Anil Kumar | Mini | Full Time | 2020-EZ-05 | 14/07/2020 | TARGETING INSULIN SIGNALLING MECHANISMS IN EXPERIMENTAL MODEL OF SPORADIC DEMENTIA OF ALZHEIMER TYPE | 30/09/2024 | No | |
| 40. | Dr Gurpal Singh Professor O P Katare |
Anil Thakur | Full Time | 2019-EZ-228 | 24/02/2020 | DEVELOPMENT OF VESICULARCARRIERS OF PACLITAXEL USING BETA-CARYOPHYLLENE AS ADJUVANT FOR THE CANCER TREATMENT | 23/02/2024 | No | |
| 41. | Professor O P Katare | Akanksha Mahajan | Full Time | 17-PHARM-11 | 09/01/2020 | SYSTEMATIC DEVELOPMENT OF NOVEL VESICULAR AND NON-VASICULAR TOPICAL FORMULATIONS OF LULICONAZOLE AND TOFACITINB CITRATE | 09/01/2024 | No | |
| 42. | Professor O P Katare | Gajanand | Full Time | 2008-Pharm-73 | 09/01/2019 | SYSTEMATIC DEVELOPMENT OF NOVEL NANO-LIPOIDAL TOPICAL FORMULATIONS OF ETODOLAC AND CYCLOSPORINE A | Yes | ICMR-RA | |
| 43. | Professor Kanwaljit Chopra Dr Mahendra Bishnoi |
Vibhu | Full Time | 16-PHARM-29 | 09/01/2019 | Role of neuronal and non-neuronal TRPA1 channels in prebiotics derived short chain fatty acids effects in colon | 31/08/2023 | Yes | National Agri Food Biotechnology Institute |
| 44. | Dr Anurag Kuhad Dr Mahendra Bishnoi (NABI, Mohali) |
Jasleen Kaur | Full Time | 12-Pharm-17 | 09/01/2019 | Studies on TRP-based triagonists for obesity prevention and therapeutics | 31/05/2023 | Yes | National Agri-Food Biotechnology Institute |
| 45. | Dr Anurag Kuhad Dr Mahendra Bishnoi (NABI, Mohali) |
Rupinder Kaur Sodhi | Full Time | 18-19/390/PhD | 21/11/2018 | PHARMACOLOGICAL INVESTIGATIONS ON ROLE OF ANKYRIN 1 AND MELASTATIN 8 TRANSIENT RECEPTOR POTENTIAL CHANNELS IN ANTIPSYCHOTICS-INDUCED METABOLIC ALTERATIONS | 21/11/2022 | Yes | SERB-DST |
| 46. | Professor Anil Kumar | Monika Kadian | Full Time | 2018-EZ-123 | 01/08/2018 | ROLE OF VOLTAGE-GATED CALCIUM CHANNEL MODULATION IN EXPERIMENTAL MODEL OF ALZHEIMER'S DISEASE | 31/07/2022 | Yes | ICMR |
| 47. | Dr Gurpal Singh Professor Bhupinder Singh Bhoop |
Anjali Pant | Full Time | 17-18/426/PhD | 15/01/2018 | Systematic Development and Characterization of Nanostructured Formulations for Early Diagnosis and Treatment of Osteoporosis | 15/01/2023 | Yes | DST INSPIRE |
| 48. | Dr Vandita Kakkar | Parina Kumari | Full Time | 17-18/500/Ph.D | 15/01/2018 | NANOCARRIER MEDIATED FORMULATION(S) OF TETRAHYDROCURCUMIN AND FOLIC ACID FOR DIABETIC FOOT ULCER | 14/01/2023 | Yes | DST INSPIRE |
| 49. | Dr Amita Sarwal | Gurpreet Singh | Full Time | 16/316/Ph.D | 02/11/2016 | DEVELOPMENT OF INTRANASL AND LONG-ACTING PARENTERAL FORMULATIONS OF DULOXETINE FOR EFFECTIVE PSYCHOTHERAPY | 02/11/2020 | Yes | Private- Jaswant Singh Gill Pharma Research Fellowship |
| 50. | Dr Vandita Kakkar | Tauqir Ashraf Sohail | Full Time | 16/164/Ph.D | 01/04/2016 | DEVELOPMENT AND EVALUATION OF TOPICAL OCULAR DELIVERY SYSTEMS OF AMINOGLYCOSIDE ANTIBIOTICS BACTERIAL CONJUNCTIVITIS | 16/06/2021 | Yes | UGC-NFOBC |
| 51. | Dr Vandita Kakkar | Komal Saini | Full Time | 16/136/Ph.D | 30/03/2016 | DEVELOPMENT OF TOPICAL NANOFORMULATIONS OF TETRAHYDROCURCUMIN AND TACROLIMUS FOR SKIN INFLAMMATION | 30/03/2021 | No | |
| 52. | Professor Indu Pal Kaur | Garima Sharma | Full Time | 16/1094/Ph.D | 14/03/2016 | SYSTEMATIC DEVELOPMENT AND EVALUATION OF TOPICAL NANOFORMULATIONS OF ADAPALENE AND RESVERATROL | 01/04/2021 | Yes | DST-PM FELLOWSHIP |
Enquiry No(s): 1800-180-2065, +91 172 2534818, 2534866 (from 9:30 am to 1:00 pm & 2:30 pm to 5:00 pm on working days )
© 1997- 2024 - Panjab University, Chandigarh, India. Developed by: Computer Centre, Panjab University | Disclaimer